Compare JFR & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | JFR | ATRC |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | JFR | ATRC |
|---|---|---|
| Price | $7.84 | $42.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $52.00 |
| AVG Volume (30 Days) | ★ 621.7K | 554.8K |
| Earning Date | 01-01-0001 | 10-29-2025 |
| Dividend Yield | ★ 11.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $518,304,999.00 |
| Revenue This Year | N/A | $16.90 |
| Revenue Next Year | N/A | $12.29 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 15.80 |
| 52 Week Low | $7.61 | $28.29 |
| 52 Week High | $8.82 | $43.11 |
| Indicator | JFR | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 70.06 |
| Support Level | $7.80 | $38.92 |
| Resistance Level | $7.96 | $42.42 |
| Average True Range (ATR) | 0.05 | 1.67 |
| MACD | 0.00 | 0.63 |
| Stochastic Oscillator | 42.50 | 94.89 |
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.